Feasibility Study to Evaluate the Use of Patient Reported Complications After Digital Consent
Launched by PORTSMOUTH HOSPITALS NHS TRUST · Apr 2, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how well patients can report any complications they experience after breast surgery, specifically for those with early invasive breast cancer. It aims to see if using electronic consent forms helps patients communicate their experiences accurately and whether the information in these forms aligns with what they actually go through. This study will help improve the consent process and determine if a new follow-up method, where patients report their own issues, is effective or if it might lead to missing some problems.
To participate, you need to be a woman aged 18 or older who has been diagnosed with early invasive breast cancer and is scheduled for a specific type of surgery called Wide Local Excision and sentinel lymph node biopsy. You should be able to complete an online questionnaire or participate in a phone interview. It’s important that you can give your consent to join the study and feel comfortable sharing your experiences. If you need an interpreter or cannot consent for yourself, you won't be eligible for this study. Participants will have the chance to share their experiences and help shape future patient care, making it a valuable opportunity.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Consent form 1- Adult patients who have the capacity to consent for themselves.
- • Female adult aged 18years or above
- • Diagnosed with early invasive breast cancer suitable for breast conserving surgery
- • Undergoing Wide Local Excision of the breast and sentinel lymph node biopsy.
- • Participant must be able to fill out an electronic questionnaire or take part in a phone questionnaire.
- • Participant is willing and able to give informed consent for participation in the study.
- Exclusion Criteria:
- • Unable to consent for themselves or do not wish to participate.
- • Patients who need an interpreter.
About Portsmouth Hospitals Nhs Trust
Portsmouth Hospitals NHS Trust is a renowned healthcare institution dedicated to delivering high-quality medical services and advancing clinical research. Located in Portsmouth, the Trust encompasses a range of hospitals and specialized units, focusing on patient-centered care and innovative treatment approaches. With a commitment to improving health outcomes, the Trust actively engages in clinical trials that contribute to the development of new therapies and the enhancement of existing medical practices. By fostering collaboration among healthcare professionals, researchers, and patients, Portsmouth Hospitals NHS Trust plays a vital role in the advancement of medical knowledge and the improvement of healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Portsmouth, Hampshire, United Kingdom
Patients applied
Trial Officials
Edward St John
Principal Investigator
Portsmouth Hospitals NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported